We are one of the Asia Pacific region’s best-equipped providers of commercial molecular diagnostic lab testing services.
Our customers include doctors, institutions and non-healthcare professionals, such as lawyers.
We are dedicated to the early detection and prevention of disease, and aim to deliver fast, effective diagnosis and treatment monitoring.
We know the importance people place on our diagnoses and are meticulous about how we operate.
We’ve made a considerable investment in advanced MDx equipment and a premium Laboratory Management System.
Our lab applies our own proprietary and patented flow-through hybridization technology, which is used in leading MDx labs around the world.
DiagCor lab services are operated by professional and experienced staff, 30% of whom are PhDs.
Our molecular and cytogenetic services cover prenatal diagnosis, genetic testing, paternity investigation, cancer diagnostics, infectious disease screening and genotyping.
DiagCor participates in CAP proficiency testing for HPV screening, chlamydia trachomatis, neisseria gonorrhoeae and paternity testing.
In 2011 the WHO conducted a proficiency study that found DiagCor GenoFlow assay proficient for detection at minimum of 5 to 500 International Units (IU) of HPV genotype 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68b. In addition, the specificity of the reported types is >97%.